Thursday, October 2, 2025 10/2/2025

Telehealth Research and Innovation for Veterans with Cancer (THRIVE)

Award Number: P50CA271358
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/15/2022
PERIOD OF PERFORMANCE END DATE: 07/31/2027

Group Awards By:

View Award Description

Telehealth Research and Innovation for Veterans with Cancer (THRIVE) - The rapid uptake of telehealth since the coronavirus pandemic has highlighted not only the potential for telehealth to improve access and quality of care for some but also how telehealth can exacerbate the “digital divide,” increasing differences in care. Social, economic, environmental, and structural factors account for 30-50% of the variance in health outcomes, far more than the 10-20% ascribed to health care. In order to achieve high quality care, it is crucial to understand these factors (e.g., rurality, race/ethnicity and poverty) and how they affect use of telehealth. The Veterans Health Administration (VA) is the largest integrated health care system in the US, providing care to 9 million patients across 171 medical centers and 1,112 outpatient sites. VA provides a unique opportunity to examine what factors affect use of telehealth for cancer across a health care system with equal access and without focus on reimbursement. Therefore, the entire VA system will serve as our clinical practice network for this Center. All three THRIVE PI’s are experts in implementation science and will use the Consolidated Framework for Implementation Research to guide our understanding of telehealth care delivery for patients with cancer and to explore and understand differences in the quality of care. We propose a Center called Telehealth Research and Innovation for Veterans with Cancer (THRIVE), whose overarching aim is two-fold: 1) to understand what factors impact the delivery of telehealth for cancer and 2) to develop methods to address these factors and thereby improve access and quality of cancer care for all patients. THRIVE will focus on four highly important and prevalent cancers within VA: lung, colon, prostate, and breast. Our findings will be extremely valuable in understanding how telehealth implementation affects the quality of cancer care for the entire population and how VA and other US health systems can leverage telehealth to improve cancer outcomes. Our Specific Aims for this Center are: (1) efficiently manage all components of THRIVE, including coordination, communication, fiscal management, recruitment and dissemination (Administrative Core); (2) Identify what factors affect telehealth use for cancer care and overall quality of care and to develop and test implementation strategies to mitigate differences in outcomes (Research and Methods Core); (3) Create a high functioning learning network to facilitate research on telehealth for cancer (Clinical Practice Network); (4) conduct a trial assessing the impact of a comprehensive, multilevel virtual oncology program on promoting engagement with telehealth and reducing differences in outcomes of care(Pragmatic Trial); and (5) Train the next generation of oncology researchers in virtual care.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $1,453,925 )
2025	2025	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Trans-NIH Research Support	002	4	9/22/2025	SUPPLEMENT FOR EXPANSION	$216,486
2025	2025	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	001	4	9/15/2025	NON-COMPETING CONTINUATION	$1,072,319
2025	2025	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Trans-NIH Research Support	003	4	9/23/2025	SUPPLEMENT FOR EXPANSION	$165,120
2025	2024	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	000	3	4/14/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,453,925

Issue Date FY: 2024 ( Subtotal = $1,033,571 )
2024	2024	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	000	3	8/28/2024	NON-COMPETING CONTINUATION	$1,033,571
2024	2024	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	001	3	9/25/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,033,571

Issue Date FY: 2023 ( Subtotal = $1,102,149 )
2023	2023	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	001	2	8/9/2023	NON-COMPETING CONTINUATION	$1,102,149
2023	2022	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	000	1	3/8/2023	NEW	$0
														Subtotal = $1,102,149

Issue Date FY: 2022 ( Subtotal = $1,128,603 )
2022	2022	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	000	1	8/15/2022	NEW	$1,128,603
														Subtotal = $1,128,603

Grand Total All Awards = $4,718,248

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Telehealth Research and Innovation for Veterans with Cancer (THRIVE)

Award Number: P50CA271358

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/15/2022

PERIOD OF PERFORMANCE END DATE: 07/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer